I share some of your concern. Michelle needs a good shakeup. I'm voting against the rem report this year to register my protest against her lack of communication and no equity ownership. I urge you to do the same.
BIT has a portfolio that has a reasonable likelihood of proving up against HIV. Zika is a good one to pursue also as it is early stages in Zika drug research, even though the virus itself was discovered in the 50s.
A story broke this morning on Bloomberg that Singapore is trying to contain the spread of Zika now. Should be online on the website soon. Am on my phone so can't link. Bodes well for BIT's focus on Zika.
Hopefully the next two weeks bring with it some solid announcements out of BIT, but I'm losing confidence in Michelle.
BIT Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held
(20min delay)